Figure 1.

Percentage utilisation of risperidone (defined daily dose (DDD) basis) versus selected atypical antipsychotic drugs among four European countries. NB. *= No statistical difference in the rate of risperidone utilisation before and after the availability of generic risperidone in separate country analyses.

Godman et al. BMC Medicine 2014 12:98   doi:10.1186/1741-7015-12-98
Download authors' original image